Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile-associated Diarrhea”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Not applicableUnknownNCT05430269
What this trial is testing

Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients

Who this might be right for
Diarrhea Caused by DrugClostridium Difficile Infections
Charles University, Czech Republic 36
Early research (Phase 1)Study completedNCT02835118
What this trial is testing

Ascending Multiple Doses of Oral Surotomycin in Healthy Participants (MK-4261-009)

Who this might be right for
Clostridium Difficile Associated Diarrhea (CDAD)
Merck Sharp & Dohme LLC 30
Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Large-scale testing (Phase 3)Study completedNCT00468728
What this trial is testing

PAR-101/OPT-80 Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 535
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Not applicableLooking for participantsNCT03895593
What this trial is testing

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Who this might be right for
Intestinal InfectionClostridioides Difficile InfectionAntibiotic-associated Diarrhea
The Second Hospital of Nanjing Medical University 100
Large-scale testing (Phase 3)Study completedNCT00328263
What this trial is testing

Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients

Who this might be right for
DiarrheaClostridium Infections
Bio-K Plus International Inc. 472
Not applicableStudy completedNCT02896244
What this trial is testing

AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment

Who this might be right for
Clostridium Difficile
MJM Bonten 1,007
Large-scale testing (Phase 3)Study completedNCT02218372
What this trial is testing

Investigate the Safety and Efficacy of Fidaxomicin (Oral Suspension or Tablets) and Vancomycin (Oral Liquid or Capsules) in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile-associated Diarrhea (CDAD)
Astellas Pharma Europe B.V. 148
Early research (Phase 1)Ended earlyNCT02589964
What this trial is testing

Probiotics in the Reduction of Antibiotic Associated Diarrhea

Who this might be right for
Clostridium Difficile
TriHealth Inc. 1
Large-scale testing (Phase 3)Study completedNCT01598311
What this trial is testing

CB-183,315 in Participants With Clostridium Difficile Associated Diarrhea (MK-4261-006)

Who this might be right for
Clostridium Difficile Infection
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 608
Large-scale testing (Phase 3)Study completedNCT00314951
What this trial is testing

Fidaxomicin Versus Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) (MK-5119-018)

Who this might be right for
Clostridium InfectionsDiarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 629
Large-scale testing (Phase 3)Study completedNCT00106509
What this trial is testing

GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated Diarrhea

Who this might be right for
Clostridium EnterocolitisPseudomembranous Colitis
Genzyme, a Sanofi Company 520
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Not applicableUnknownNCT03368105
What this trial is testing

Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain

Who this might be right for
Clostridium Difficile
Medical University of Silesia 300
Not applicableLooking for participantsNCT01905709
What this trial is testing

Fecal Microbiota Transplantation for C Diff Infection

Who this might be right for
Clostridium Difficile Infection
Englewood Hospital and Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00382304
What this trial is testing

The Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea

Who this might be right for
Pseudomembranous ColitisClostridium Difficile DiarrheaAntibiotic-Associated Diarrhea
Genzyme, a Sanofi Company 24
Large-scale testing (Phase 3)Study completedNCT00269399
What this trial is testing

A Trial to Compare Xifaxan to Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Clostridium InfectionsDiarrhea
Bausch Health Americas, Inc. 237
Testing effectiveness (Phase 2)Study completedNCT00097422
What this trial is testing

OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)

Who this might be right for
Diarrhea
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Post-approval studies (Phase 4)Ended earlyNCT02200328
What this trial is testing

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

Who this might be right for
Clostridium Difficile Diarrhea
Alison Schneider 76
Load More Results